
Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BIOCON | BSE
2.00
0.85%
Healthcare
Biotechnology
30/09/2023
30/11/2023
238.45
238.45
239.10
236.10
Biocon Limited a biopharmaceutical company manufactures pharmaceuticals and medicinal chemical and botanical products. The company operates through Generics Novel Biologics Biosimilars and Research Services segments. It focuses in the areas of diabetes oncology immunology ophthalmology and bone health diseases. In addition It is involved in the integrated discovery development and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru India.
View LessLow 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
Midcap (2B - 10B USD)
Weak P/E, and PEG ratio indicator
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
13.1%1 month
11.9%3 months
24.0%6 months
28.0%56.44
0
3.40
0.96
0.33
17.23
3.84
0
32.43B
286.47B
3.44B
0.64
10.18
169.20
49.30
4.07
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
10.75
Range1M
21.60
Range3M
62.45
Rel. volume
0.63
Price X volume
23.72M